Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Short term its being beaten down by day traders and short sellers. About 3.5 mil short volume last I checked. Anyways I'm averaging down more shares for Monday.

I think the upcoming IND for retinal scarring macular degeneration will put a huge spotlight on RXII. As there are no drugs approved for scarring and no drugs approved for scarring of macular degeneration.

I will continue to hold long-term because I know that this company will not be trading where its at one year from now when we see the new early results in hypertrophic scars and keloids.